Ledibiox is indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults.
Daklibiox is indicated for use with sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 3 infection.
Sobiovir indicated for the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen.
Nevirapine: Biovirapine is indicated for use in combination with other antiretroviral agents for the treatment of HIV-1-infection.
Valacyclovir: Herpes genitalis Herpes zoster
Valgancyclovir: For treatment of CMV-infections
Tenofovir disoproxil fumarate:Tenobiovir is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection or chronic hepatitis B virus infection in patients who are also infected with HIV.
Efabiovir in combination with other antiretroviral agents is indicated for the treatment of HIV-1 infection.
Zidovudine / Lamivudine: This Combination is indicated in the treatment of HIV infection.
Adefovir: Biofovir is indicated for the treatment of chronic hepatitis B in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.